氧化苦参碱
传统医学
化学
肝纤维化
药物发现
药理学
医学
纤维化
天然产物
生物
生物信息学
生物化学
病理
作者
Xiao Ma,Yinxiao Jiang,Jianxia Wen,Yanling Zhao,Jinhao Zeng,Yaoguang Guo
标识
DOI:10.1016/j.ejphar.2020.173578
摘要
The discovery of drugs to treat liver fibrosis has long been a challenge over the past decades due to its complicated pathogenesis. As a primary approach for drug development, natural products account for 30% of clinical drugs used for disease treatment. Therefore, natural products are increasingly important for their medicinal value in liver fibrosis therapy. In this part of the review, special focus is placed on the effect and mechanism of natural compounds, including alkaloids, terpenoids, glycosides, coumarins and others. A total of 36 kinds of natural compounds demonstrate significant antifibrotic effects in various liver fibrosis models in vivo and in hepatic stellate cells (HSCs) in vitro. Revealing the mechanism will provide further basis for clinical conversion, as well as accelerate drug discovery. The mechanism was further summarized with the finding of network regulation by several natural products, such as oxymatrine, paeoniflorin, ginsenoside Rg1 and taurine. Moreover, there are still improvements needed in investigating clinical efficacy, determining mechanisms, and combining applications, as well as semisynthesis and modification. Therefore, natural products area promising resource for agents that protect against liver fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI